 |
|
A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
Jong Geol Do, Young Bum Kim, Dae Gu Lee, Ji Hye Hwang
Ann Rehabil Med. 2012;36(6):880-886. Published online 2012 Dec 28 DOI: https://doi.org/10.5535/arm.2012.36.6.880
|
|
Citations to this article as recorded by
 Late Onset Nephrogenic Systemic Fibrosis in a Patient with Stage 3 Chronic Kidney Disease: a Case Report
Yu Jeong Lim, Jisun Bang, Youngsun Ko, Hyun-Min Seo, Woon Yong Jung, Joo Hark Yi, Sang-Woong Han, Mi-yeon Yu
Journal of Korean Medical Science.2020;[Epub] CrossRef Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists
Nicola Schieda, Pejman Jabehdar Maralani, Casey Hurrell, Anne K. Tsampalieros, Swapnil Hiremath
Canadian Association of Radiologists Journal.2019; 70(3): 226. CrossRef A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis
Hanieh Attari, Yan Cao, Tina R. Elmholdt, Yize Zhao, Martin R. Prince
Radiology.2019; 292(2): 376. CrossRef Fibrotic Signaling Pathways of Skin Fibroblasts in Nephrogenic Systemic Fibrosis
Saranya Ravi, Christopher J. Sayed
Current Geriatrics Reports.2019; 8(4): 338. CrossRef Gadolinium-Based Contrast Agents in Kidney Disease: Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Nicola Schieda, Jason I. Blaichman, Andreu F. Costa, Rafael Glikstein, Casey Hurrell, Matthew James, Pejman Jabehdar Maralani, Wael Shabana, An Tang, Anne Tsampalieros, Christian van der Pol, Swapnil Hiremath
Canadian Association of Radiologists Journal.2018; 69(2): 136. CrossRef Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists
Nicola Schieda, Jason I. Blaichman, Andreu F. Costa, Rafael Glikstein, Casey Hurrell, Matthew James, Pejman Jabehdar Maralani, Wael Shabana, An Tang, Anne Tsampalieros, Christian B. van der Pol, Swapnil Hiremath
Canadian Journal of Kidney Health and Disease.2018; 5: 205435811877857. CrossRef T1hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?
Nigel Hoggard, Giles H Roditi
The British Journal of Radiology.2017; 90(1069): 20160590. CrossRef Gadolinium‐based contrast agents: A comprehensive risk assessment
Tyler J. Fraum, Daniel R. Ludwig, Mustafa R. Bashir, Kathryn J. Fowler
Journal of Magnetic Resonance Imaging.2017; 46(2): 338. CrossRef The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during 99mTc‐MDP bone scintigraphy
Lin Qiu, Yuhui Tang, Yue Chen, Zhanwen Huang, Yan Zhu, Li Zhang, Liang Cai, Qiang Wan, Yue Feng
Contrast Media & Molecular Imaging.2015; 10(6): 438. CrossRef A Practical Guide to MR Imaging Safety: What Radiologists Need to Know
Leo L. Tsai, Aaron K. Grant, Koenraad J. Mortele, Justin W. Kung, Martin P. Smith
RadioGraphics.2015; 35(6): 1722. CrossRef Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era
Laura K. Thomson, Peter C. Thomson, David B. Kingsmore, Karen Blessing, Conal D. Daly, Shawn E. Cowper, Giles H. Roditi
Journal of Magnetic Resonance Imaging.2015; 41(5): 1268. CrossRef MR Contrast Agent Safety in the Age of Nephrogenic Systemic Fibrosis: Update 2014
Johannes Budjan, Stefan O. Schoenberg, John N. Morelli, Stefan Haneder
Current Radiology Reports.2014;[Epub] CrossRef Current status of nephrogenic systemic fibrosis
L. Daftari Besheli, S. Aran, K. Shaqdan, J. Kay, H. Abujudeh
Clinical Radiology.2014; 69(7): 661. CrossRef Sclerotic bodies beyond nephrogenic systemic fibrosis
Jag Bhawan, Tanya A. Perez‐Chua, Lynne Goldberg
Journal of Cutaneous Pathology.2013; 40(9): 812. CrossRef
|